Artículos Científicos

pubmed-logo-white
DATE: 2020/11/13
[Low-risk alcohol drinking limits based on associated mortality.]
Rev Esp Salud Publica. 2020 Nov 13;94:e202011167.
AUTHORS: Sordo L, Córdoba R, Gual A, Sureda X.
PMID: 33185196
MORE INFO
DATE: 2020/11/07
Alcohol Control Policy in Europe: Overview and Exemplary Countries
Int J Environ Res Public Health. 2020 Nov 4;17(21):8162. doi: 10.3390/ijerph17218162.
AUTHORS: Berdzuli N, Ferreira-Borges C, Gual A, Rehm J.
PMID: 33158307
MORE INFO
DATE: 2020/09/25
Phosphatidylethanol for Monitoring Alcohol Use in Liver Transplant Candidates: An Observational Study
J Clin Med. 2020 Sep 22;9(9):3060. doi: 10.3390/jcm9093060.
AUTHORS: Barrio P, Gual A, Lligoña A, Teixidor L, Weinmann W, Yegles M, Wurst FM.
PMID: 32971960
MORE INFO
DATE: 2020/09/23
Predictors of Changes in Alcohol Craving Levels during a Virtual Reality Cue Exposure Treatment among Patients with Alcohol Use Disorder
J Clin Med. 2020 Sep 18;9(9):3018. doi: 10.3390/jcm9093018.
AUTHORS: Hernández-Serrano O, Ghiţă A, Figueras-Puigderrajols N, Fernández-Ruiz J, Monras M, Ortega L, Mondon S, Teixidor L, Gual A, Ugas-Ballester L, Fernández M, Montserrat R, Porras-Garcia B, Ferrer-Garcia M, Gutiérrez-Maldonado J.
PMID: 32962176
MORE INFO
DATE: 2020/08/26
A systematic review of treatments for alcohol-related cognitive impairment: lessons from the past and gaps for future interventions
Psychol Med. 2020 Oct;50(13):2113-2127. doi: 10.1017/S0033291720002925. Epub 2020 Aug 25.
AUTHORS: Caballeria E, Oliveras C, Nuño L, Balcells-Oliveró M, Gual A, López-Pelayo H.
PMID: 32840195
MORE INFO
DATE: 2020/08/23
Active Smoking Before Liver Transplantation in Patients with Alcohol Use Disorder: Risk Factors and Outcomes
J Clin Med. 2020 Aug 21;9(9):2710. doi: 10.3390/jcm9092710.
AUTHORS: López-Lazcano AI, Gual A, Colmenero J, Caballería E, Lligoña A, Navasa M, Crespo G, López E, López-Pelayo H.
PMID: 32825794
MORE INFO
DATE: 2020/08/10
Sex-specific Associations of Alcohol Withdrawal in Patients Admitted for the Treatment of Alcohol Use Disorder
J Addict Med. 2021 Jan-Feb 01;15(1):68-73. doi: 10.1097/ADM.0000000000000704.
AUTHORS: Sanvisens A, Zuluaga P, Short A, Rubio G, Gual A, Torrens M, Fuster D, Bolao F, Rodríguez de Fonseca F, Muga R; CohRTA study.
PMID: 32769772
MORE INFO
DATE: 2020/08/01
«The post-COVID era»: challenges in the treatment of substance use disorder (SUD) after the pandemic
BMC Med. 2020 Jul 31;18(1):241. doi: 10.1186/s12916-020-01693-9.
AUTHORS: López-Pelayo H, Aubin HJ, Drummond C, Dom G, Pascual F, Rehm J, Saitz R, Scafato E, Gual A.
PMID: 32731868
MORE INFO
DATE: 2020/07/30
Implementing primary healthcare-based measurement, advice and treatment for heavy drinking and comorbid depression at the municipal level in three Latin American countries: final protocol for a quasiexperimental study (SCALA study)
BMJ Open. 2020 Jul 28;10(7):e038226. doi: 10.1136/bmjopen-2020-038226.
AUTHORS: Jané-Llopis E, Anderson P, Piazza M, O’Donnell A, Gual A, Schulte B, Pérez Gómez A, de Vries H, Natera Rey G, Kokole D, V Bustamante I, Braddick F, Mejía Trujillo J, Solovei A, Pérez De León A, Kaner EF, Matrai S, Manthey J, Mercken L, López-Pelayo H, Rowlands G, Schmidt C, Rehm J.
PMID: 32723746
MORE INFO
DATE: 2020/06/27
e-INEBRIA Special Interest Group Roadmap for Best Practices for Research on Brief Digital Interventions for Problematic Alcohol and Illicit Drug Use
J Med Internet Res. 2020 Aug 14;22(8):e20368. doi: 10.2196/20368.
AUTHORS: Schaub MP, Berman AH, López Pelayo H, Boumparis N, Khadjesari Z, Blankers M, Gual A, Riper H, Pas L.
PMID: 32586786
MORE INFO